Primary Site >> Colorectal Cancer
Gene >> CD40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Lineage-specific induction of B cell apoptosis and altered signal transduction by the phosphotyrosine phosphatase inhibitor bis(maltolato)oxovanadium(IV). PMID: 7657667 |
Ref: Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells. PMID: 10365667 Ref: CD154 inhibits tumor-induced apoptosis in dendritic cells and tumor growth. PMID: 10427977 Ref: Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response. PMID: 10429676 |
Ref: Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors. PMID: 10891436 Ref: Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma. PMID: 10986558 Ref: In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity. PMID: 11001366 |
Ref: Dendritic cell infiltration in colon cancer. PMID: 11265770 Ref: Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens. PMID: 11391614 Ref: Dendritic Cell Infiltration in Colon Cancer. PMID: 11449069 Ref: A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice. PMID: 11591784 |
Ref: Increased expression of CD40 ligand on activated T cells of patients with colon cancer. PMID: 11948126 Ref: Modulation of dendritic cell differentiation and maturation by decoy receptor 3. PMID: 11994433 Ref: Cell surface phenotyping and cytokine production of Epstein-Barr Virus (EBV)-transformed lymphoblastoid cell lines (LCLs). PMID: 12191505 Ref: Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10. PMID: 12209589 Ref: [Inhibition of human glioma cell growth by a soluble recombinant human CD40 ligand]. PMID: 12508655 |
Ref: OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. PMID: 12496388 Ref: Dendritic cell-induced activation of adaptive and innate antitumor immunity. PMID: 14634094 |
Ref: Transcriptional regulation of TNF family receptors and Bcl-2 family by chemotherapeutic agents in murine CT26 cells. PMID: 14743399 Ref: In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunity. PMID: 15027495 Ref: Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice. PMID: 15256474 Ref: Immune properties of recombinant vaccinia virus encoding CD154 (CD40L) are determined by expression of virally encoded CD40L and the presence of CD40L protein in viral particles. PMID: 15359290 Ref: Coexpression of CD40 and CD40L on B lymphoma and carcinoma cells: an autocrine anti-apoptotic role. PMID: 15360007 Ref: Expression of interleukin-22 in murine carcinoma cells did not influence tumour growth in vivo but did improve survival of the inoculated hosts. PMID: 15541036 |
Ref: Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96. PMID: 15867395 Ref: Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells. PMID: 15912532 |
Ref: Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma. PMID: 17335294 Ref: CD40-mediated death and cytokine secretion in colorectal cancer: a potential target for inflammatory tumour cell killing. PMID: 17534894 Ref: [Effects of two different antigen-loading methods on the activity of dendritic cell vaccine for colorectal carcinoma cell inhibition in vitro]. PMID: 17545041 |
Ref: Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma. PMID: 18351578 Ref: Expression of CD40 and growth-inhibitory activity of CD40 ligand in colon cancer ex vivo. PMID: 18603231 |
Ref: Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer. PMID: 19383782 Ref: CD1d-based combination therapy eradicates established tumors in mice. PMID: 19620318 |
Ref: Induction of tolerogenic dendritic cells by IL-6-secreting CT26 colon carcinoma. PMID: 21999714 |
Ref: Infiltration of CD40-positive tumor-associated macrophages indicates a favorable prognosis in colorectal cancer patients. PMID: 22687258 Ref: [Effect of Achyranthes bidentata polysaccharides stimulated dendritic cells co-cultured with cytokine induced killer cells against SW480 cells]. PMID: 23847957 |
Ref: Potential role of soluble CD40 ligand as inflammatory biomarker in colorectal cancer patients. PMID: 24706377 Ref: [Anti-tumor effect of Sendai virus Tianjin strain defective interfering particles on tumor-bearing mice]. PMID: 24785276 Ref: Combination anti-CD137 and anti-CD40 antibody therapy in murine myc-driven hematological cancers. PMID: 24934848 |
Ref: Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironment. PMID: 25351848 Ref: Polymeric microparticles for sustained and local delivery of antiCD40 and antiCTLA-4 in immunotherapy of cancer. PMID: 25993015 |
Ref: Body composition of the host influences dendritic cell phenotype in patients treated for colorectal cancer. PMID: 26960692 Ref: Induction of immunogenic cell death by radiation-upregulated karyopherin alpha 2 in vitro. PMID: 27107455 Ref: Immunotherapy of Colorectal Cancer. PMID: 27259331 Ref: Regulation of CD40 signaling in colon cancer cells and its implications in clinical tissues. PMID: 27262846 Ref: T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells. PMID: 27622331 |
Ref: Pro-inflammatory chitosan/poly(gamma-glutamic acid) nanoparticles modulate human antigen-presenting cells phenotype and revert their pro-invasive capacity. PMID: 28919508 Ref: Expression of CD40/CD40L in colon cancer, and its effect on proliferation and apoptosis of SW48 colon cancer cells. PMID: 29155517 |
Ref: The apoptotic effects of Brucea javanica fruit extract against HT29 cells associated with p53 upregulation and inhibition of NF-kappaB translocation. PMID: 29636600 Ref: The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell-mediated Antitumor Immune Response Through Activation of Antigen-presenting Cells. PMID: 30273198 |